Sun Pharma and Cosmo announce territory expansion of license and supply agreements for WINLEVI
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.